Bicycle Therapeutics (BCYC) Change in Account Payables (2018 - 2026)

Bicycle Therapeutics has reported Change in Account Payables for 9 years, with the latest figure at -$3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 23.53% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at -$5.7 million (down 242.29% YoY), and the FY2025 full-year result was -$6.9 million, down 322.0% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$3.8 million, down from -$2.9 million in the prior quarter.
• The five-year high for Change in Account Payables was $10.7 million in Q4 2024, with the low at -$5.9 million in Q1 2024.
• Historically, Change in Account Payables has averaged $173470.6 across 5 years, with a median of -$431000.0 in 2024.
• Annual changes were most pronounced in 2023 — Change in Account Payables plunged 684.71% — and 2025, when it soared 1515.08%.
• Bicycle Therapeutics' Change in Account Payables stood at -$2.4 million in 2022, then jumped by 275.82% to $4.2 million in 2023, then surged by 156.49% to $10.7 million in 2024, then plunged by 126.96% to -$2.9 million in 2025, then plunged by 33.22% to -$3.8 million in 2026.
• The last three Change in Account Payables figures came in at -$3.8 million (Q1 2026), -$2.9 million (Q4 2025), and -$5.1 million (Q3 2025), per Business Quant data.